Published : Nov 2019
Tables : 50
Figures : 44
Category : Healthcare
No. of Pages : 235
Report Code : HC-U2250
The Global Gastrointestinal Drugs Market is forecasted to value over USD xxx billion by 2026 end and register a CAGR of xx% from the forecast period 2019-2026. FutureWise Market Research has illustrated a report on the Gastrointestinal Drugs Market. The report provides an in-depth anatomy of Gastrointestinal Drugs Market trends affecting its growth. Moreover, it includes intricate insights on profitability graph, Gastrointestinal Drugs Market share, SWOT analysis and geographical augmentation of this business. Furthermore, the report provides information on the status of key market players in the competitive landscape analysis of Gastrointestinal Drugs Market. The Gastrointestinal Drugs Market is projected to achieve significant growth by the end of the forecast period as per the research study conducted by FutureWise research analysts. The report explains that this business is predicted to record a remarkable growth rate over the forecast period. This report provides important information regarding the total valuation that this industry holds presently and it also lists the segmentation of the Gastrointestinal Drugs Market along with the growth opportunities present across this business vertical. Major players included in the Gastrointestinal Drugs market are • Allergan • Abbott Laboratories • AstraZeneca • Bayer • Boehringer Ingelheim • Sanofi • GlaxoSmithKline • Janssen Biotech • Takeda Pharmaceutical • Valeant Pharmaceuticals (Note: The list of the major players will be updated with the latest market scenario and trends) Gastrointestinal Drugs Market Segmentation: By Product Type • Acid Neutralizers • Antidiarrheal and Laxatives • Antiemetic and Antinauseants • Anti-inflammatory Drugs • Biologics • Others By Application • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies By Region • North America • Europe • Asia-Pacific • Rest of the world Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Gastrointestinal Drugs Market by product type, by application and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization services offered are free of charge with purchase of any license of the report. • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1 Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.2.1 Markets Covered 1.2.2 Years Considered for the Study 1.3 Currency 1.4 Limitations 1.5 Stakeholders 2 Research Methodology 2.1 Research Approach 2.2 Research Data 2.2.1 Secondary Sources 2.2.1.1 Key Data from Secondary Sources 2.2.2 Primary Sources 2.2.2.1 Key Data from Primary Sources 2.2.2.2 Breakdown of Primary Interviews 2.3 Market Size Estimation 2.4 Market Breakdown and Data Triangulation 2.5 Research Assumptions 3 Executive Summary 4. Market Overview 4.1. Introduction 4.1.1. Industry Evolution / Developments 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Gastrointestinal Drugs Market Analysis and Forecast, 2019–2026 4.4.1. Global Gastrointestinal Drugs Market Value (US$ Mn) Projections 4.5. Porter’s Five Force Analysis 5. Global Gastrointestinal Drugs Market Analysis and Forecast, by Product Type 5.1. Introduction & Definition 5.2. Key Findings / Developments 6. Global Gastrointestinal Drugs Market Analysis and Forecast, by Application 6.1. Introduction & Definition 6.2. Key Findings / Developments 7. Global Gastrointestinal Drugs Market Analysis and Forecast, by Region 7.1. Key Findings 7.2. Global Gastrointestinal Drugs Market Value Forecast, by Region 7.2.1. North America 7.2.2. Europe 7.2.3. Asia Pacific 7.2.4. Rest of the world 8 Competition Landscape 8.1. Market Player – Competition Matrix (By Tier and Size of companies) 8.2. Market Share Analysis by Company (2019) 8.3. Market Footprint Analysis 8.3.1. By Region 8.4. Competitive Business Strategies 9 Company Profiles 9.1. Allergan 9.1.1. Company Overview (HQ, Business Segments, Employee Strength) 9.1.2. Product Portfolio 9.1.3. SWOT Analysis 9.1.4. Financial Overview 9.1.5. Strategic Overview 9.2. ABBOTT LABORATORIES 9.2.1. Company Overview (HQ, Business Segments, Employee Strength) 9.2.2. Product Portfolio 9.2.3. SWOT Analysis 9.2.4. Financial Overview 9.2.5. Strategic Overview 9.3. AstraZeneca 9.3.1. Company Overview (HQ, Business Segments, Employee Strength) 9.3.2. Product Portfolio 9.3.3. SWOT Analysis 9.3.4. Financial Overview 9.3.5. Strategic Overview 9.4. Bayer 9.4.1. Company Overview (HQ, Business Segments, Employee Strength) 9.4.2. Product Portfolio 9.4.3. SWOT Analysis 9.4.4. Financial Overview 9.4.5. Strategic Overview 9.5. Boehringer Ingelheim 9.5.1. Company Overview (HQ, Business Segments, Employee Strength) 9.5.2. Product Portfolio 9.5.3. SWOT Analysis 9.5.4. Financial Overview 9.5.5. Strategic Overview 9.6. Sanofi 9.6.1. Company Overview (HQ, Business Segments, Employee Strength) 9.6.2. Product Portfolio 9.6.3. SWOT Analysis 9.6.4. Financial Overview 9.6.5. Strategic Overview 9.7. GlaxoSmithKline 9.7.1. Company Overview (HQ, Business Segments, Employee Strength) 9.7.2. Product Portfolio 9.7.3. SWOT Analysis 9.7.4. Financial Overview 9.7.5. Strategic Overview 9.8. Janssen Biotech 9.8.1. Company Overview (HQ, Business Segments, Employee Strength) 9.8.2. Product Portfolio 9.8.3. SWOT Analysis 9.8.4. Financial Overview 9.8.5. Strategic Overview 9.9. Takeda Pharmaceutical 9.9.1. Company Overview (HQ, Business Segments, Employee Strength) 9.9.2. Product Portfolio 9.9.3. SWOT Analysis 9.9.4. Financial Overview 9.9.5. Strategic Overview 9.10. Valeant Pharmaceuticals 9.10.1. Company Overview (HQ, Business Segments, Employee Strength) 9.10.2. Product Portfolio 9.10.3. SWOT Analysis 9.10.4. Financial Overview 9.10.5. Strategic Overview 10 Research Finding and Conclusion 11 Research Methodology 12 Research Data Source
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics